Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins

Clinical Nephrology

Volumn 73, Issue 1, 2010, Pages 30-35

  Takagi, Kan ^a   Masuda, K ^a   Yamazaki, M ^a   Kiyohara, C ^b   Itoh, S ^b   Wasaki, M ^a   Inoue, H ^c  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anemia; Colestilan; Hemodialysis; Nutrition; Phosphate binder ion exchange resins; Sevelamer hydrochloride

Indexed keywords

ASCORBIC ACID; COBALT; COLESTILAN; COPPER; CYANOCOBALAMIN; FOLIC ACID; ION EXCHANGE RESIN; IRON; METAL ION; PHOSPHATE BINDING AGENT; PYRIDOXINE; SEVELAMER; VITAMIN; VITAMIN K GROUP; ZINC;

ADSORPTION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG MIXTURE; FLAME PHOTOMETRY; GLOMERULUS FILTRATION; HEMATOPOIESIS; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PH;

EID: 74049118856     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP73030     Document Type: Article

References (34)

1. Agarwal, AK. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc. 2006; 7: S7-S12.
2. Allen RI, Box KJ, Comer EA, Peake C, Tam KY. Multiwavelength spectrophotometric determination of acid dissociation of ionizable drugs. J Pharm Biomed Anal. 1998; 17: 699-712.
3. Bossola M, Muscaritoli M, Tazza L, Panocchia N, Liberatori M, Giungi S, Tortorelli A, Fanelli FR, Luciani G. Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr. 2005; 15: 244-252.
4. Fishman SM, Christian P, West KP Jr. The role of vitamins in the prevention and control of anaemia. Public Health Nutr. 2000; 3: 125-150.
5. Furuland H, Linde T, Ahlmén J, Christensson A, Strömbom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant. 2003; 18: 353-361.
6. Goldsmith DR, Scott LJ, Cvetkovic RS, Plosker GL. Sevelamer hydrochloride a review of its use for hyperphosphataemia in patients with end-stage renal disease in haemodialysis. Drugs. 2008; 68: 85-104.
7. Gouva C, Nikolopoulos P, Ioannidis JPA, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004; 66: 753-760.
8. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000; 35: 250-256.
9. Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, Fujita T, Fukuda N, Soma M, Matsumoto K. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med. 2006; 45: 271-273.
10. Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008; 74:148-157.
11. International Union of Pure and Applied Chemistry. IUPAC Chemical Data Series, No. 21, "Stability Constants of Metal-Ion Complexes, Part A: Inorganic Ligands". Oxford: Pergamon Press; 1982.
12. Iseki K, Kohagura K. Anemia as a risk factor for chronic kidney disease. Kidney Int. 2007; 72: S4-S9.
13. Iwasaki S, Suzuki R, Nomura K, Hasegawa T, Ito Y, Yoshimura A, Ideura T. Oral zinc supplementation reduces mean erythropoietin dose in EPO-required hemodialysis. J Am Soc Nephrol. 2001; 12: 357A.
14. Japanese Society of Dialysis Therapy. Guideline for Renal Anemia in Chronic Hemodialysis Patients. Nippon Touseki Igakukai Zasshi. 2004; 37: 1737-1763 (Japanese).
15. Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton). 2007; 12: 321-330.
16. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr. 2002; 12: 17-31.
17. Kalantar-Zedeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003; 10: 170-182.
18. Kolthoff IM, Elving IM. Treatise on Analytical Chemistry, part I Theory and Practice, 2nd Eds., Volume 2, Section D: Solution Equilibria and Chemistry, Chapter 20-21. New York; JohnWiley & Sons; 1979.
19. Kwack C, Balakrishnan VS. Managing erythropoietin hyporesponsiveness. Semin Dial. 2006; 19: 146-151.
20. Lederer E, Ouseph R. Chronic kidney disease. Am J Kidney Dis. 2007; 49: 162-171.
21. Locatelli F, Aljama P, Bárány P, Canaud B, Carrera F, Eckardt KU, Hörl WH, Macdougall IC, Macleod A, Wiecek A, Cameron S. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004; 19: 1-47.
22. Locatelli F, DelVecchio L, Pozzoni P. Treating anemia at different stages of renal disease. J Nephrol. 2007; 20: S33-S38.
23. Maeda M. Trace elements related to anemia. Biomed Res Trace Elements. 2005; 16: 19-24.
24. Mahajan SK, Bowersox EM, Rye DL, Abu-Hamdan DK, Prasad AS, McDonald FD, Biersack KL. Factors underlying abnormal zinc metabolism in uremia. Kidney Int. 1989; 36: S269-273.
25. Moriwaki K, Kanno Y, Nakamoto H, Okada H, Suzuki H. Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis. Adv Perit Dial. 2002; 16: 308-312.
26. National Kidney Foundation. NKF-DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000; 35: S1-S140.
27. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006; 47: S11-S145.
28. National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis. 2007; 50: 471-530.
29. Olivares R. Important considerations in iron management and nutritional status in select hemodialysis populations. Nephrol Nurs J. 2007; 34: 425-432.
30. Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis. 1995; 25: 548-554.
31. Schaefer RM, Teschner M, Kosch M. Folate metabolism in renal failure. Nephrol Dial Transplant. 2002; 17: 24-27.
32. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006; 38: 295-310.
33. Xia J, Browing JD, O'Dell BL. Decreased plasma membrane thiol concentration is associated with increased osmotic fragility of erythrocytes in zinc-deficient rats. J Nutr. 1999; 129: 814-819.
34. Zalunardo N, Levin A. Anemia and the heart in chronic kidney disease. Semin Nephrol. 2006; 26: 290-295.